The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population‐Based Study
Antispasmodic use in patients with IBD was associated with increased abdominal pain and opioid use in opioid-naïve patients. Antispasmodic use was associated with increased likelihood of corticosteroid use, clinic and ER visits and hospitalisation.
Authors
- Chachrit Khunsriraksakul (ORCID: https://orcid.org/0000-0001-5131-1229)
- Audrey S. Kulaylat
- Dajiang J. Liu (ORCID: https://orcid.org/0000-0001-6553-858X)
- Olivia Ziegler (ORCID: https://orcid.org/0000-0003-2348-6683)
- Matthew Coates (ORCID: https://orcid.org/0000-0001-8976-5015)
Institutions
- Pennsylvania State University (US)
- Johns Hopkins Hospital (US)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1111/apt.70147
- Citations
- 5
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 9.06
Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases